Armata Pharmaceuticals, Inc. (ARMP) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -5.78M | -6.67M | -4.3M | -7.21M | -7.58M | -7.93M | -8.86M | -10.18M | -10.58M | -8.11M | -9.69M | -12.06M | -17.57M | -10.48M | -10.33M | -8.15M | -3.52M | -8.6M | -4.96M | -4.54M |
| Operating CF Margin % | -732.83% | - | - | -332.46% | -1543.79% | -641.86% | -298.12% | - | -1095.65% | -530.5% | -790.78% | -1230.61% | -2207.29% | -997.62% | -772.27% | -432.71% | -284.39% | -869.36% | -396.8% | -388.53% |
| Operating CF Growth % | 23.72% | 15.81% | 51.51% | 29.14% | 28.38% | 2.21% | 8.51% | 15.61% | 39.76% | 22.69% | 6.25% | -48.01% | -399.86% | -21.95% | -108.16% | -79.55% | 35.8% | -36.43% | -27.94% | -17.69% |
| Net Income | -115.35M | -124.3M | -26.68M | -16.3M | -6.53M | 2.6M | -5.48M | 8.99M | -25.02M | -19.85M | -31.16M | -3.55M | -14.49M | -10.31M | -8.61M | -9.21M | -8.77M | -6.05M | -5.42M | -6.19M |
| Depreciation & Amortization | 457K | 418K | 370K | 366K | 377K | 380K | 313K | 315K | 317K | 293K | 221K | 228K | 230K | 245K | 226K | 195K | 226K | 277K | 314K | 297K |
| Stock-Based Compensation | 1.07M | 632K | 622K | 575K | 781K | 354K | 670K | 1.33M | 534K | 193K | -373K | 261K | 857K | 817K | 846K | 949K | 493K | 664K | 469K | 907K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.86M | 0 | 0 | 0 | 0 | 0 | 0 | 3.22M | -722K | 0 |
| Other Non-Cash Items | 107.13M | 116.61M | 19.57M | 10.14M | -1.01M | -12.45M | -3.32M | -20.15M | 15.28M | 11.06M | 17.67M | -6.04M | 3.16M | 0 | 1.22M | 0 | 0 | -3.22M | -2K | 0 |
| Working Capital Changes | 899K | -33K | 1.81M | -2M | -1.2M | 1.19M | -1.05M | -661K | -1.69M | 197K | 92K | -2.97M | -7.33M | -1.23M | -4.01M | -77K | 4.54M | -3.49M | 396K | 452K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 679K | -69K | 16K | -647K | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -352K | -310K | 794K | -265K | -553K | -1.72M | 0 | -654K | -1.49M | 0 | -437K | 1.46M | -1.34M | 3.08M | -1.04M | 682K | 940K | 184K | 0 | 0 |
| Cash from Investing | -63K | -52K | -242K | -149K | -99K | 77K | -340K | -1.37M | -250K | -2.39M | -3.51M | -222K | -2.01M | 455K | -1.29M | -1.14M | -236K | -228K | -582K | -196K |
| Capital Expenditures | -63K | -52K | -242K | -149K | -99K | 77K | -340K | -1.37M | -250K | -2.4M | -3.51M | -222K | -2.01M | 455K | -1.29M | -1.14M | -236K | -228K | -582K | -196K |
| CapEx % of Revenue | 7.98% | - | - | 6.87% | 20.16% | 6.23% | 11.44% | - | 25.88% | 157.07% | 286.69% | 22.65% | 252.51% | 43.29% | 96.71% | 60.33% | 19.09% | 23.05% | 46.52% | 16.78% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 641K | 658K | 14.97M | 0 | 9.99M | 0 | -61K | 88K | 34.93M | -43K | 24.8M | -368K | 29.59M | -500K | 31K | -146K | 44.63M | 7.04M | 86K | -185K |
| Debt Issued (Net) | 0 | 0 | 15M | 0 | 10M | -34.89M | 0 | 0 | 34.89M | 0 | 24.8M | -368K | 29.59M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 704K | 658K | 0 | 0 | -14K | 0 | -61K | 88K | 42K | -43K | 5K | 0 | 0 | 0 | -23K | -217K | 44.63M | 6.96M | 0 | -185K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | -14K | 0 | -61K | 0 | 0 | -43K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -63K | 0 | -32K | 0 | 0 | 34.89M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -500K | 54K | 71K | 0 | 82K | 86K | 0 |
| Net Change in Cash | -5.2M | -6.07M | 10.43M | -7.36M | 2.31M | -7.85M | -9.26M | -11.46M | 24.34M | -10.54M | 11.61M | -12.65M | 10.01M | -10.53M | -11.6M | -9.43M | 40.88M | -1.79M | -5.46M | -4.92M |
| Free Cash Flow | -5.84M | -6.73M | -4.54M | -7.36M | -7.68M | -7.85M | -9.2M | -11.54M | -10.83M | -10.51M | -13.2M | -12.28M | -19.58M | -10.03M | -11.63M | -9.28M | -3.75M | -8.83M | -5.55M | -4.73M |
| FCF Margin % | -740.81% | - | - | -339.33% | -1563.95% | -635.63% | -309.55% | - | -1121.53% | -687.57% | -1077.47% | -1253.27% | -2459.8% | -954.33% | -868.98% | -493.04% | -303.48% | -892.42% | -443.33% | -405.31% |
| FCF Growth % | 23.88% | 14.32% | 50.67% | 36.24% | 29.12% | 25.28% | 30.28% | 6.02% | 44.67% | -4.75% | -13.52% | -32.29% | -421.99% | -13.64% | -109.65% | -96.11% | 35.03% | -32.36% | -40.02% | -14.65% |
| FCF per Share | -0.16 | -0.19 | -0.13 | -0.20 | -0.21 | -0.13 | -0.25 | -0.20 | -0.30 | -0.29 | -0.37 | -0.34 | -0.54 | -0.28 | -0.32 | -0.26 | -0.13 | -0.34 | -0.22 | -0.19 |
| FCF Conversion (FCF/Net Income) | 0.05x | 0.05x | 0.16x | 0.44x | 1.16x | -3.05x | 1.62x | -1.13x | 0.42x | 0.41x | 0.31x | 3.40x | 1.21x | 1.02x | 1.20x | 0.88x | 0.40x | 1.42x | 0.92x | 0.73x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |